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Background
  Clear Lake High School
  Career Exploration Program
  CSA Internship Extension
  Interests in biochemistry – how 
can we change the chemistry
of the body using medications?
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The Pharmacology Discipline
“Risk of Clinically Relevant Unpredicted 
Effects of Medication”
  Medication usage
  Medication stability
  Spaceflight and pharmacokinetics
  Spaceflight and pharmacodynamics
  Spaceflight and antimicrobials
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Project Involvement Highlights
  Pharmacology Risk Evidence Book Update
  FeRad Experiment
  Research Proposal
  Current status of therapies to treat or prevent radiation 
damage
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Pharmacology Evidence Book
  What is the evidence book?
  Update using the most recent literature.
  Learning how to understand and critically evaluate 
scientific literature
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FeRad Experiment – Introduction 
  Mouse liver cells on short-term shuttle flights (STS-
135) have been shown to exhibit changes
  By replicating aspects of spaceflight in the laboratory, 
we can conduct experiments without impacting mission 
resources
  Astronauts are on a high-iron diet during spaceflight
  Galactic Cosmic Rays (GCRs) and Solar Particle 
Events (SPEs) are ionizing radiation sources that can 
alter physiological functions
  Preliminary medication usage data from the 
International Space Station (ISS) crew shows that the 
most common reasons for using medications in space 
are the same for healthy people on earth
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FeRad Experiment – Gene Expression
  The process by which genetic information is used to 
create a functional gene product, mainly proteins
  Environmental factors like radiation can change the 
amount of gene product
  Changes in gene product can result from changes in 
transcription, translation, or other functionally specific 
intermediate steps
  Example: increase in amount of RNA transcribed
  A change in expression high in the chain does not 
guarantee a change in gene product expression
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Transcription Translation
DNA RNA Gene Product
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FeRad Experiment – Drug Metabolism
  Enzymes are a type of protein that act as highly 
selective catalysts for biological reactions
  Medications are generally metabolized by enzymes in 
the liver – leading to their activation or inactivation
  The largest group of drug metabolizing enzymes is the 
Cytochrome P450 enzyme superfamily
  The substrates, or reactants of the P450 superfamily 
includes metabolic intermediates (lipids and 
hormones) and xenobiotics (drugs and other 
chemicals)
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FeRad Experiment – Polymerase Chain Reaction
  Used to determine whether there was a change in 
RNA expression of a gene
  Multi-step process
Total RNA Isolation
Conversion of all RNA to cDNA
Use of primers to ensure only one gene is copied 
during duplication cycles
Addition of fluorophore that glows in the presence of 
double-stranded DNA
Repeated duplication of one gene sequence in the 
thermocycler
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FeRad Experiment – Polymerase Chain Reaction
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Gene A
Gene B
The initial presence of more cDNA copies of Gene A causes it 
to reach the lumonisity threshold ~10 cycles before Gene B.
This implies there was more RNA for Gene A expressed than 
there was for Gene B.
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FeRad Experiment – Western Blotting
  Use of gel electrophoresis to 
separate out all of a cell’s 
proteins by molecular weight
  Proteins are then transferred to 
a less-fragile nitrocellulose 
membrane
  The membrane is rinsed with 
antibodies that bind only to the 
protein of interest
  A fluorophore is bound to the 
antibody
  The membrane is scanned, and 
the light of the fluorophore is 
measured
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Polyacrylamide Gel
Proteins
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FeRad Experiment – Western Blotting
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Western blot for the drug metabolism protein 
Cyp2e1. Molecular weight marker is on the 
leftmost lane.
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FeRad Experiment – Initial Results
  Some (but not all) of the enzymes that metabolize 
medications are found in far greater quantities in the 
liver after exposure to radiation and/or high iron. 
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Research Proposal – Introduction 
  Wrote a proposal to study the effects of radiation and a 
high-iron diet on oxidative stress in tissues of differing 
metabolic rates
  Better understanding of scientific design
  Was able to apply knowledge gained from 
shadowing Kami Faust on the FeRad experiment
Career Exploration Program
Exit Presentation 14
National Aeronautics and Space Administration
Research Proposal – Overview  
  Made use of existing samples
  Determine the differences (if any) in oxidative stress 
responses of tissues of differing metabolic activity
High glycolytic – fast twitch muscle fibers
Intermediate – liver tissue
Low glycolytic – slow twitch muscle fibers
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JSC Experiences
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Human Research Program Conference
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CEP Award Ceremony
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Summer Intern Collaboration
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Future Plans
  Grand Valley State University
  B.S. in Chemistry
  Undergraduate research
  Graduate School
  Work in pharmaceutical industry
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Thank You!
  Dr. Virginia Wotring
  Kami Faust
  Ashley Kappenman
  Carolyn Snyder
  Missy Matthias
  Nick Gardner
  Dr. Lauren Merkle
  Jacqueline Reeves
  Cristi Richardson
  Beth Marshall
  Victoria Hood
  Allen Hood 
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